Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review.

In this report, we aim to add to the existing body of evidence regarding a link between anti- tumor necrosis factor alpha (anti-TNF-α) treatment and demyelination leading to neurological disorders, specifically Guillain Barré syndrome (GBS), and treatment with an interleukin-17A (IL17A) antagonist as a safe alternative for ankylosing spondylitis (AS). A literature review was carried out of current research concerning anti-TNF-α and induced GBS. Only papers published in English were reviewed and only peer-reviewed journals searched.

X-ray crystal structures of [XeF][MF6] (M = As, Sb, Bi), [XeF][M2F11] (M = Sb, Bi) and estimated thermochemical data and predicted stabilities for noble-gas fluorocation salts using volume-based thermodynamics.

The crystal structures of the xenon(II) salts, [XeF][SbF(6)], [XeF][BiF(6)], and [XeF][Bi(2)F(11)], have been determined for the first time, and those of XeF(2), [XeF][AsF(6)], [XeF][Sb(2)F(11)], and [XeF(3)][Sb(2)F(11)] have been redetermined with greater precision at -173 °C. The Bi(2)F(11)(-) anion, which has a structure analogous to those of the As(2)F(11)(-) and Sb(2)F(11)(-) anions, has been structurally characterized by single crystal X-ray diffraction for the first time as its XeF(+) salt. The fluorine bridge between the bismuth atoms is asymmetric with Bi---F(b) bond lengths of 2.